EPAM reported a decrease in revenue by 2.0% year-over-year to $1.147 billion for Q2 2024. GAAP diluted EPS was $1.70, a decrease of $0.33 year-over-year, while non-GAAP diluted EPS was $2.45, a decrease of $0.19 year-over-year. The company narrows full year revenue guidance to $4.590 billion to $4.625 billion.
Revenues decreased to $1.147 billion, a year-over-year decrease of 2.0%.
GAAP income from operations was 10.5% of revenues and non-GAAP income from operations was 15.2% of revenues.
GAAP diluted EPS was $1.70, a decrease of $0.33 year-over-year, and non-GAAP diluted EPS was $2.45, a decrease of $0.19 year-over-year.
The Board of Directors approved a new share repurchase program with authorization to purchase up to $500 million of EPAM common stock.
EPAM expects revenues for the full year to be between $4.590 billion and $4.625 billion. For the third quarter, EPAM expects revenues to be in the range of $1.145 billion to $1.155 billion, GAAP diluted EPS to be in the range of $1.75 to $1.83 and non-GAAP diluted EPS to be in the range of $2.65 to $2.73.